SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda

被引：5
|
作者：
Mugisha, Joseph [1 ]
Mpairwe, Bernard [1 ]
Newton, Robert [1 ,2 ]
Cotten, Matthew [1 ,3 ,4 ]
Phan, My V. T. [1 ]
机构：
[1] Uganda Virus Res Inst, Uganda Res Unit, MRC, Entebbe, Uganda
[2] Univ York, York, England
[3] Univ Glasgow Ctr Virus Res, MRC, Glasgow, Scotland
[4] UVRI & LSHTM, MRC, Uganda Res Unit, POB 49,Plot 51-59,Nakiwogo Rd, Entebbe, Uganda
来源：
EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 01期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
D O I：
10.3201/eid2901.220981
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We describe a cluster of COVID-19 breakthrough infec-tions after vaccination in Kyamulibwa, Kalungu District, Uganda. All but 1 infection were from SARS-CoV-2 Omi-cron strain BA.5.2.1. We identified 6 distinct genotypes by genome sequencing. Infections were mild, suggest-ing vaccination is not protective against infection but may limit disease severity.
引用
收藏
页码：224 / 226
页数：3
相关论文
共 50 条
  • [21] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tomokazu Tamura
    Daichi Yamasoba
    Yoshitaka Oda
    Jumpei Ito
    Tomoko Kamasaki
    Naganori Nao
    Rina Hashimoto
    Yoichiro Fujioka
    Rigel Suzuki
    Lei Wang
    Hayato Ito
    Yukie Kashima
    Izumi Kimura
    Mai Kishimoto
    Masumi Tsuda
    Hirofumi Sawa
    Kumiko Yoshimatsu
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Jun Kanamune
    Yutaka Suzuki
    Yusuke Ohba
    Isao Yokota
    Keita Matsuno
    Kazuo Takayama
    Shinya Tanaka
    Kei Sato
    Takasuke Fukuhara
    Communications Biology, 6
  • [22] Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
    Fujita, Shigeru
    Kosugi, Yusuke
    Kimura, Izumi
    Yamasoba, Daichi
    Sato, Kei
    VIRUSES-BASEL, 2022, 14 (12):
  • [23] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tamura, Tomokazu
    Yamasoba, Daichi
    Oda, Yoshitaka
    Ito, Jumpei
    Kamasaki, Tomoko
    Nao, Naganori
    Hashimoto, Rina
    Fujioka, Yoichiro
    Suzuki, Rigel
    Wang, Lei
    Ito, Hayato
    Kashima, Yukie
    Kimura, Izumi
    Kishimoto, Mai
    Tsuda, Masumi
    Sawa, Hirofumi
    Yoshimatsu, Kumiko
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Suzuki, Yutaka
    Ohba, Yusuke
    Tabata, Kaori
    Yokota, Isao
    Matsuno, Keita
    Takayama, Kazuo
    Tanaka, Shinya
    Sato, Kei
    Fukuhara, Takasuke
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [24] Individuals with weaker humoral response after second booster vaccination are prone to SARS-CoV-2 Omicron BA.5 infections
    Moehlendick, B.
    Ciuciulkaite, I.
    Elsner, C.
    Wagner, B.
    Dittmer, U.
    Siffert, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S5 - S5
  • [25] Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters
    Kim Handrejk
    Katharina S. Schmitz
    Edwin J. B. Veldhuis Kroeze
    Laura L. A. van Dijk
    Peter van Run
    Bart Haagmans
    Anne Moscona
    Matteo Porotto
    Rik L. de Swart
    Rory D. de Vries
    Melanie Rissmann
    npj Viruses, 2 (1):
  • [26] Emergence of SARS-CoV-2 Omicron BA.5 variant of concern in Western Pennsylvania, United States
    Phan, Tung
    Boes, Stephanie
    McCullough, Melissa
    Gribschaw, Jamie
    Marsh, Jane W.
    Harrison, Lee H.
    Wells, Alan
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4593 - 4594
  • [27] Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants
    Malato, Joao
    Ribeiro, Ruy M.
    Leite, Pedro P.
    Casaca, Pedro
    Fernandes, Eugenia
    Antunes, Carlos
    Fonseca, Valter R.
    Gomes, Manuel C.
    Graca, Luis
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (10): : 953 - 954
  • [28] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Touret, Franck
    Baronti, Cecile
    Pastorino, Boris
    Villarroel, Paola Mariela Saba
    Ninove, Laetitia
    Nougairede, Antoine
    de Lamballerie, Xavier
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
    Shrestha, Lok Bahadur
    Foster, Charles
    Rawlinson, William
    Tedla, Nicodemus
    Bull, Rowena A.
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (05)
  • [30] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Franck Touret
    Cécile Baronti
    Boris Pastorino
    Paola Mariela Saba Villarroel
    Laetitia Ninove
    Antoine Nougairède
    Xavier de Lamballerie
    Scientific Reports, 12
12345